BridgeBio Pharma BBIO Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $14.4B.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's market capitalization?
- BridgeBio Pharma (BBIO) reported market capitalization of $14.4B in Q1 2026.
- How has BridgeBio Pharma's market capitalization changed year-over-year?
- BridgeBio Pharma's market capitalization increased by 119.0% year-over-year, from $6.57B to $14.4B.
- What is the long-term trend for BridgeBio Pharma's market capitalization?
- Over 5 years (2020 to 2025), BridgeBio Pharma's market capitalization has grown at a 7.1% compound annual growth rate (CAGR), from $10.47B to $14.74B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.